ConductScience.org, home

Paper41313745

Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.

Martin JD and 19 others. Adv Sci (Weinh), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer. Papers, record 41313745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41313745

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.
PubMed
Journal
Adv Sci (Weinh)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Immune Checkpoint InhibitorsMajor topic
DexamethasoneMajor topic
Breast NeoplasmsMajor topic
Adrenal Cortex HormonesMajor topic
Animals
Mice
Female
Disease Models, Animal
Glucocorticoids
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
18H05378Grants-in-Aid Challenging ResearchPubMed
23H00546Grants-in-Aid for Scientific Research APubMed
22K19541Grants-in-Aid for Exploratory ResearchPubMed
21KK0197Promotion of Joint International ResearchPubMed
Ministry of Education, Culture, Sports, Science and TechnologyPubMed
European Regional Development FundPubMed
INFRASTRUCTURE/1216/0052Research Promotion FoundationPubMed
POST-DOC/0718/0084Research Promotion FoundationPubMed
P16731Japan Society for the Promotion of SciencePubMed
ERC-2013-StG-336839HORIZON EUROPE European Research CouncilPubMed
ERC-2018-PoC-838414HORIZON EUROPE European Research CouncilPubMed
ERC-2019-CoG-863955HORIZON EUROPE European Research CouncilPubMed
JP17cm0106202Japan Agency for Medical Research and DevelopmentPubMed

Source PubMed

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129664018Increased vessel perfusion predicts the efficacy of immune checkpoint blockade.J Clin Invest2018https://conductscience.org/library/papers/29664018PubMed
225739764Immunological mechanisms of the antitumor effects of supplemental oxygenation.Sci Transl Med2015https://conductscience.org/library/papers/25739764PubMed
325924065Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.Nature2015https://conductscience.org/library/papers/25924065PubMed
429455927Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.Cancer Cell2018https://conductscience.org/library/papers/29455927PubMed
532042344TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.Theranostics2020https://conductscience.org/library/papers/32042344PubMed
633465258Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy.Oncologist2021https://conductscience.org/library/papers/33465258PubMed
737778345Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.Oncology2024https://conductscience.org/library/papers/37778345PubMed
832658626Antiemetics: ASCO Guideline Update.J Clin Oncol2020https://conductscience.org/library/papers/32658626PubMed
916224268Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.J Immunother2005https://conductscience.org/library/papers/16224268PubMed
1023897981Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.J Exp Med2013https://conductscience.org/library/papers/23897981PubMed
1131187975Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment.ACS Nano2019https://conductscience.org/library/papers/31187975PubMed
1215965952CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients.J Cell Physiol2006https://conductscience.org/library/papers/15965952PubMed
1330755690The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.Nat Rev Cancer2019https://conductscience.org/library/papers/30755690PubMed
1433239433Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma.Clin Cancer Res2021https://conductscience.org/library/papers/33239433PubMed
1525477332Trafficking of T cells into tumors.Cancer Res2014https://conductscience.org/library/papers/25477332PubMed
1629508855Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29508855PubMed
1734106045Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.Elife2021https://conductscience.org/library/papers/34106045PubMed
188402656Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.Cancer Res1993https://conductscience.org/library/papers/8402656PubMed
1939886162Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer.BMJ Oncol2024https://conductscience.org/library/papers/39886162PubMed
2023045683Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/23045683PubMed

See all 49 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41313745

GET https://conductscience.org/api/papers/v1/41313745/references?page=2